Black C, Larson D, Rollberg B, A
Yu P, Han W, Villar VA, Yang Y, Lu Q, Lee H, et al
Risk Factors for Mood Changes During GLP-1 Therapy Patients with a personal or family history of depression, anxiety, or bipolar disorder may face higher risk of mood destabilization during semaglutide treatment
In the post-intervention network, reduced interaction density was observed between dysregulated metabolites and genes including SRM , ODC1 , and AMD1 , which are involved in polyamine biosynthesis and methylation pathways
Growth Hormone Pulse Dynamics In endocrine research, this combination is studied for its ability to mimic the natural, pulsatile rhythm of GH release
Disclaimer: All products purchased on this website are intended for laboratory and research purposes only